WHO ICTRP trial
A study to evaluate the safety of excessive consumption of blue rose extract…
JPRN-UMIN000059547 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000059547 |
|---|---|
| Public title | A study to evaluate the safety of excessive consumption of blue rose extract powder |
| Scientific title | A study to evaluate the safety of excessive consumption of blue rose extract powder: an open-label study - A study to evaluate the safety of excessive consumption of blue rose extract powder |
| Primary sponsor | KINJIRUSHI Co., LTD. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Healthy Japanese |
| Interventions | Duration: 4weeks Test product: Aurum Blue(R) Rose Ex M (KRE-101) (500 mg/day) Administration: Consume two capsules with water at any time once daily. *If a dose is missed, it should be consumed as soon as remembered. The daily dose should… |
| Registration date | Oct 27, 2025 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: